|
|
| | Myosin modulator 1 Basic information |
| Product Name: | Myosin modulator 1 | | Synonyms: | Myosin modulator 1;3(2H)-Quinazolineacetamide, N-[(1R)-1-(5-cyano-3-fluoro-2-pyridinyl)ethyl]-5,6-difluoro-1,4-dihydro-2-oxo- | | CAS: | 3034189-56-2 | | MF: | C18H14F3N5O2 | | MW: | 389.33 | | EINECS: | | | Product Categories: | | | Mol File: | 3034189-56-2.mol |  |
| | Myosin modulator 1 Chemical Properties |
| Boiling point | 648.5±55.0 °C(predicted) | | density | 1.49±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted) | | pka | 12.27±0.20(predicted) |
| | Myosin modulator 1 Usage And Synthesis |
| Uses | Myosin modulator 1 (Compound B141) is a modulator for myosin, that inhibits ATPase in rabbits psoas, porcine atria and in porcine ventricle, with IC25s of 0.42, 0.13 and 3.09 μM, respectively. Myosin modulator 1 regulates systolic cardiac performance in Sprague Dawley rats[1]. | | References | [1] Hawryluk N, et al., 1,4-dihydroquinazolinone compounds and uses thereof. WO2024073426A1. |
| | Myosin modulator 1 Preparation Products And Raw materials |
|